Align Technology | ALGN - Equity Capital And Reserves

Stock Price
175.62
Daily Change
14.32 8.88%
Monthly
4.75%
Yearly
-19.58%
Q1 Forecast
158.01

Align Technology reported $3.96B in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
3M USD 4.75B 119M Dec/2025
Align Technology USD 3.96B 44.68M Sep/2025
Becton, Dickinson and Co. USD 25.39B 82M Sep/2025
Bruker USD 2.49B 625.6M Sep/2025
Cardinal Health USD -2.88B 5M Dec/2025
Charles River Laboratories USD 3.41B 52.13M Sep/2025
Cooper Companies USD 8.35B 64.9M Jun/2025
CVS Health USD 72.93B 4.45B Sep/2025
Danaher USD 52.53B 1.46B Dec/2025
Dentsply International USD 1.48B 482M Sep/2025
Dexcom USD 2.73B 153M Sep/2025
Henry Schein USD 3.36B 84M Sep/2025
Idexx Laboratories USD 1.56B 5.97B Sep/2025
Insulet USD 1.38B 78.8M Sep/2025
Integra LifeSciences USD 1.04B 1.09M Sep/2025
IQVIA Holdings USD 6.5B 343M Dec/2025
Masimo USD 810M 232.8M Sep/2025
McKesson USD -1.3B 441M Dec/2025
Mettler Toledo International USD -23.64M 225.56M Dec/2025
Revvity USD 7.38B 180.27M Sep/2025
Solventum Corp USD 4.99B 1.34B Sep/2025
Stryker USD 21.78B 594M Sep/2025
Teleflex USD 3.82B 421M Sep/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025
Veeva Systems USD 7.04B 402.09M Sep/2025
Waters USD 2.33B 170.88M Sep/2025
Zimmer Biomet Holdings USD 12.77B 231.7M Sep/2025
Zoetis USD 5.4B 421M Sep/2025